(LYB) LyondellBasell Industries - Overview
Stock: Olefins, Polyolefins, Polyethylene, Polypropylene, Catalysts
| Risk 5d forecast | |
|---|---|
| Volatility | 42.5% |
| Relative Tail Risk | -4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.26 |
| Alpha | -37.09 |
| Character TTM | |
|---|---|
| Beta | 1.258 |
| Beta Downside | 1.643 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.35% |
| CAGR/Max DD | -0.20 |
EPS (Earnings per Share)
Revenue
Description: LYB LyondellBasell Industries January 02, 2026
LyondellBasell Industries N.V. (NYSE: LYB) is a global chemical producer headquartered in Houston, Texas, with operations spanning the United States, Europe, Asia and Latin America.
The firm is organized into six operating segments: Olefins & Polyolefins (Americas, Europe/Asia/International), Intermediates & Derivatives, Advanced Polymer Solutions, Refining, and Technology licensing.
Its product slate includes core olefins (ethylene, propylene, butadiene), polyolefins (PE, PP), specialty polymers (catalloy, polybutene-1), propylene-oxide derivatives, and refined fuels, plus a suite of compounded plastics, masterbatches, and engineered composites for packaging, automotive, and coatings markets.
Key data points: FY 2023 adjusted EBITDA was roughly $5.5 billion with an EBITDA margin near 14 %; net debt stood at about $13 billion, yielding a net-debt/EBITDA ratio of ~2.4×. The company’s polyolefin capacity exceeds 8.5 million t/yr, making it one of the world’s largest producers, and its earnings are highly sensitive to natural-gas feedstock prices and the ethylene-propene spread, both of which are driven by macro-level demand in construction, packaging and automotive sectors.
For a deeper, data-driven dive into LYB’s valuation metrics, the ValueRay platform offers a transparent, model-backed view worth checking out.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -743.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 1.17m > 0.02 and ΔFCF/TA 117.1m > 1.0 |
| NWC/Revenue: -0.00% < 20% (prev 15.85%; Δ -15.85% < -1%) |
| CFO/TA 4.24m > 3% & CFO 2.67b > Net Income -743.0m |
| Net Debt (-3.45b) to EBITDA (1.19b): -2.91 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (322.0m) vs 12m ago -1.23% < -2% |
| Gross Margin: 9.00% > 18% (prev 0.13%; Δ 887.3% > 0.5%) |
| Asset Turnover: 168.7% > 50% (prev 98.15%; Δ 70.56% > 0%) |
| Interest Coverage Ratio: -0.40 > 6 (EBITDA TTM 1.19b / Interest Expense TTM 507.0m) |
Altman Z'' 10.00
| A: -0.35 (Total Current Assets 630.0 - Total Current Liabilities 852.0) / Total Assets 630.0 |
| B: 11.7m (Retained Earnings 7.40b / Total Assets 630.0) |
| C: -0.01 (EBIT TTM -205.0m / Avg Total Assets 17.87b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 23.06b) |
| Altman-Z'' Score: 38.3m = AAA |
What is the price of LYB shares?
Over the past week, the price has changed by +7.88%, over one month by +19.63%, over three months by +38.69% and over the past year by -16.48%.
Is LYB a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 13
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the LYB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.1 | -11.4% |
| Analysts Target Price | 51.1 | -11.4% |
| ValueRay Target Price | 66.8 | 15.9% |
LYB Fundamental Data Overview February 09, 2026
P/S = 0.4695
P/B = 1.6733
P/EG = 1.2485
Revenue TTM = 30.15b USD
EBIT TTM = -205.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 10.64b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.22b USD (from shortTermDebt, two quarters ago)
Debt = 13.22b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -3.45b USD (from netDebt column, last quarter)
Enterprise Value = 27.50b USD (17.74b + Debt 13.22b - CCE 3.45b)
Interest Coverage Ratio = -0.40 (Ebit TTM -205.0m / Interest Expense TTM 507.0m)
EV/FCF = 37.27x (Enterprise Value 27.50b / FCF TTM 738.0m)
FCF Yield = 2.68% (FCF TTM 738.0m / Enterprise Value 27.50b)
FCF Margin = 2.45% (FCF TTM 738.0m / Revenue TTM 30.15b)
Net Margin = -2.46% (Net Income TTM -743.0m / Revenue TTM 30.15b)
Gross Margin = 9.00% ((Revenue TTM 30.15b - Cost of Revenue TTM 27.44b) / Revenue TTM)
Gross Margin QoQ = 6.49% (prev 11.73%)
Tobins Q-Ratio = 43.7m (set to none) (Enterprise Value 27.50b / Total Assets 630.0)
Interest Expense / Debt = 0.81% (Interest Expense 107.0m / Debt 13.22b)
Taxrate = 21.0% (US default 21%)
NOPAT = -161.9m (EBIT -205.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.74 (Total Current Assets 630.0 / Total Current Liabilities 852.0)
Debt / Equity = 1.25 (Debt 13.22b / totalStockholderEquity, two quarters ago 10.60b)
Debt / EBITDA = -2.91 (Net Debt -3.45b / EBITDA 1.19b)
Debt / FCF = -4.67 (Net Debt -3.45b / FCF TTM 738.0m)
Total Stockholder Equity = 11.79b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.16% (Net Income -743.0m / Total Assets 630.0)
RoE = -6.30% (Net Income TTM -743.0m / Total Stockholder Equity 11.79b)
RoCE = -0.91% (EBIT -205.0m / Capital Employed (Equity 11.79b + L.T.Debt 10.64b))
RoIC = -0.70% (negative operating profit) (NOPAT -161.9m / Invested Capital 23.21b)
WACC = 6.32% (E(17.74b)/V(30.95b) * Re(10.55%) + D(13.22b)/V(30.95b) * Rd(0.81%) * (1-Tc(0.21)))
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.62%
[DCF Debug] Terminal Value 78.55% ; FCFF base≈1.08b ; Y1≈707.9m ; Y5≈323.0m
Fair Price DCF = 39.02 (EV 9.11b - Net Debt -3.45b = Equity 12.56b / Shares 321.9m; r=6.32% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -83.03 | EPS CAGR: -58.05% | SUE: -3.95 | # QB: 0
Revenue Correlation: -92.94 | Revenue CAGR: -15.20% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.404 | Revisions Net=-3 | Analysts=13
EPS current Year (2026-12-31): EPS=2.58 | Chg30d=-0.870 | Revisions Net=-2 | Growth EPS=+52.0% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=3.82 | Chg30d=-1.005 | Revisions Net=-3 | Growth EPS=+47.9% | Growth Revenue=+0.5%